
Evidence That P-glycoprotein Inhibitor (Elacridar)-Loaded Nanocarriers Improve Epidermal Targeting of an Anticancer Drug via Absorptive Cutaneous Transporters Inhibition
Keywords: nanoemulsion; P-glycoprotein inhibition; elacridar; paclitaxel; skin cancer;